BioSpace News Archive

Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that, on December 29, 2020 , it has completed the transactions contemplated by the previously reported Addendum to a Share Purchase Agreement, dated November 29, 2020 (the “Addendum

EV Biologics Corp (OTC:YECO) today announced that it has completed all its filings on OTC Markets with its 10K, 2020 filing today. The Company expects to become Pink Current within the next few weeks, then apply for a OTCQB listing. For the Company, being current allows the majority of brokers to trade in our shares, whereas before only online brokers could buy or sell the security.

Neos Therapeutics, Inc., a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a pre-recorded presentation as part of the H.C. Wainwright Virtual BioConnect Conference.

XOMA Corporation announced its Chief Executive Officer, Jim Neal, will present at two upcoming investor conferences:

Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.

Galecto, Inc., a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced that Hans Schambye, Chief Executive Officer, will participate in two panel discussions at the LifeSci Partners 10th Annual Healthcare Corporate Access Event, which is being held virtually from January 6-8 and 11-14.

Bioasis Technologies Inc. is pleased to announce that Dr. Deborah Rathjen, Executive Chair will be attending the following industry conferences:.

- COVID-19 Patient Assistance Program: Eligible patients can continue to enroll in our Diabetes Patient Assistance Program and receive a free 90-day supply of insulin until June 30, 2021 - My$99Insulin Program: Patients who enrolled in the cash card program in 2020 must reregister to determine if they are eligible to continue participating in 2021

Nelipak® Corporation (“Nelipak”), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, announced today that Pat Chambliss has been named the company’s Chief Executive Officer. Chambliss, current President and Chief Operating Officer of Nelipak, brings to the Chief Executive Officer role an extensive track record of senior leadership experience in the packaging industry, including previous roles at P

Perspectum Announces American Medical Association Issues Unique Category III CPT ® Codes for Liver MultiScan ® Quantitative Multiparametric MR SAN FRANCISCO--( BUSINESS WIRE )-- The American Medical Association (AMA) has issued two new Current Procedural Terminology (CPT ® ) codes for Quantitative Multiparametric MR to report Liver MultiScan , which can help clinicians diagnose and treat patients with liver disease. This press release features multimedi